Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Modern anti-HIV therapy.

M Flepp¹, V Schiffer, R Weber

¹Abteilung Infektionskrankheiten und Spitalhygiene, Departement für Innere Medizin, Universitätsspital Zürich, Switzerland.

Swiss Medical Weekly

|June 13, 2001

Summary

Highly active antiretroviral therapies (HAART) effectively suppress HIV but do not eradicate it, leading to challenges with long-term adherence and side effects. Early treatment is debated due to these complexities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017.

HIV medicine·2019

Same author

Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study.

HIV medicine·2012

Same author

Infectious diseases publications in leading medical journals--a comparative analysis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2012

Same author

HLA-Bw4 identifies a population of HIV-infected patients with an increased capacity to control viral replication after structured treatment interruption.

HIV medicine·2012

Same author

Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients.

HIV medicine·2011

Same author

High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease.

BMC infectious diseases·2011

Area of Science:

Infectious Diseases
Virology
Pharmacology

Background:

Highly active antiretroviral therapies (HAART) have significantly improved outcomes for HIV-infected individuals since 1996.
HAART, typically combining nucleoside reverse transcriptase inhibitors (NRTIs) and protease inhibitors (PIs), achieves durable viral suppression and immune recovery.

Purpose of the Study:

To review the successes and challenges associated with HAART in HIV management.
To discuss the evolving treatment paradigms and the complexity of antiretroviral therapy.

Main Methods:

Literature review of HAART efficacy, adherence, and side effects.
Analysis of current recommendations for initiating and managing antiretroviral treatment.

Main Results:

HAART leads to over 80% reduction in morbidity and mortality, with undetectable HIV-RNA in over half of patients.
Challenges include incomplete viral eradication, patient non-compliance, and poorly understood side effects.
The number of available antiretrovirals and their interactions has increased exponentially, complicating treatment decisions.

Conclusions:

The dogma of early HAART initiation is being challenged due to treatment complexities and side effects.
Consultation with an HIV specialist is crucial for optimizing and managing HAART regimens.
Personalized treatment strategies are essential for effective long-term HIV care.

Related Experiment Videos